(Q59487603)

English

Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival

scientific article published on 01 May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Nikita Makretsov

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Erika Yorida

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Dmitry Turbin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Karen Gelmon

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sam M Wiseman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Torsten O Nielsen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

David G Huntsman

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1770-1777

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Prognostic and predictive factors in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of ErbB inhibitors in trastuzumab resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of epidermal growth factor receptor in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-4 protein expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

The FUTURE of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: targeting multiple receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20970

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20970

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15770691%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59487603&oldid=1986778822"